Raymond James & Associates’s Avantax, Inc. Common Stock AVTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-17,947
Closed -$299K 4249
2021
Q1
$299K Sell
17,947
-257
-1% -$4.31K ﹤0.01% 3359
2020
Q4
$290K Buy
18,204
+5,739
+46% +$70K ﹤0.01% 3144
2020
Q3
$117K Sell
12,465
-1,905
-13% -$21.1K ﹤0.01% 3358
2020
Q2
$164K Sell
14,370
-6,712
-32% -$84.3K ﹤0.01% 3183
2020
Q1
$254K Buy
21,082
+1,645
+8% +$31.7K ﹤0.01% 2878
2019
Q4
$508K Sell
19,437
-4,867
-20% -$109K ﹤0.01% 2731
2019
Q3
$526K Buy
24,304
+4,900
+25% +$124K ﹤0.01% 2613
2019
Q2
$589K Sell
19,404
-1,347
-6% -$44.3K ﹤0.01% 2548
2019
Q1
$693K Buy
20,751
+5,547
+36% +$162K ﹤0.01% 2439
2018
Q4
$405K Sell
15,204
-51,024
-77% -$1.56M ﹤0.01% 2685
2018
Q3
$2.67M Buy
66,228
+56,113
+555% +$2.04M ﹤0.01% 1638
2018
Q2
$374K Sell
10,115
-1,432
-12% -$46.2K ﹤0.01% 2875
2018
Q1
$284K Buy
11,547
+35
+0.3% +$832 ﹤0.01% 2915
2017
Q4
$254K Sell
11,512
-43,488
-79% -$969K ﹤0.01% 2923
2017
Q3
$1.39M Buy
55,000
+12,209
+29% +$276K ﹤0.01% 1887
2017
Q2
$907K Buy
42,791
+1,710
+4% +$33.8K ﹤0.01% 2086
2017
Q1
$711K Buy
41,081
+7,274
+22% +$114K ﹤0.01% 2178
2016
Q4
$499K Buy
+33,807
New +$456K ﹤0.01% 2335
2014
Q4
Sell
-42,396
Closed -$646K 2323
2014
Q3
$646K Buy
42,396
+23,461
+124% +$388K ﹤0.01% 1746
2014
Q2
$357K Buy
+18,935
New +$357K ﹤0.01% 1984
2014
Q1
Sell
-12,930
Closed -$377K 2149
2013
Q4
$377K Buy
+12,930
New +$349K ﹤0.01% 1772

Other funds holding AVTA

Raymond James & Associates's AVTA Position: Q2 2021 in Review

Raymond James & Associates sold out of Avantax, Inc. Common Stock (AVTA) in Q2 2021, closing a stake of 17,947 shares — an estimated $299K sold.

Raymond James & Associates first reported a position in AVTA in Q4 2013 and held it in 21 quarters. The position peaked at $2.67M in Q3 2018. 155 funds tracked by Wall St. Rank hold AVTA as of Q2 2021.

  • Raymond James & Associates reported no remaining Avantax, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Raymond James & Associates sold 17,947 Avantax, Inc. Common Stock shares in Q2 2021, an estimated $299K.
  • Raymond James & Associates first reported a position in Avantax, Inc. Common Stock in Q4 2013 and held it in 21 quarters.
  • Raymond James & Associates's Avantax, Inc. Common Stock position peaked at $2.67M in Q3 2018.
  • 155 funds tracked by Wall St. Rank held Avantax, Inc. Common Stock as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.